← FDA DRUG APPROVALS

FDA ANDA · ANDA075237

SOTALOL HYDROCHLORIDE

Sponsor: NOVITIUM PHARMA

APPLICATION
ANDA075237
TYPE
ANDA
ORIGINAL APPROVAL
2000-05-01
LATEST ACTION
2015-09-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SOTALOL HYDROCHLORIDEDiscontinued
SOTALOL HYDROCHLORIDE 160MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEDiscontinued
SOTALOL HYDROCHLORIDE 80MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEDiscontinued
SOTALOL HYDROCHLORIDE 240MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEDiscontinued
SOTALOL HYDROCHLORIDE 120MG · TABLET · ORAL

Approval history

2015-09-01Labeling · Supplement 8 · standardAP
2015-09-01Labeling · Supplement 6AP
2002-10-31Labeling · Supplement 3AP
2002-06-24Manufacturing (CMC) · Supplement 2AP
2000-10-13Labeling · Supplement 1AP
2000-05-01OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →